Furthermore, EMT is one of the key resistance mechanisms against EGFR-TKIs including other mechanisms such as the ’gatekeeper’ T790M mutation, histologic transformation from NSCLC to small-cell lung cancer, and concurrent molecular or genetic alterations [23]. This evidence concerns the gene EGFR and small cell lung carcinoma.